SEC Form 4/A · accession 0001209191-18-057738
Atara Biotherapeutics, Inc. · ATRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Joel S Marcus
Director
Period of report
Oct 21, 2014
Accepted (ET)
Nov 8, 2018 · 4:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604464
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 21, 2014 | P | 9,090 | $11.00 | A | 9,090 | D |
Table II — derivative securities
No Table II lines on this filing.